Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7-year clinical experience
Authors:
- 14 June 2011
- journal article
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 118 (11) , 1340-1348
Abstract
To evaluate the diagnostic performance of noninvasive fetal blood group genotyping. Descriptive analysis. Dutch national reference laboratory for pregnancies complicated by alloimmunisation. All consecutive alloimmunised pregnant women for whom fetal blood group genotyping of rhesus D, c, E or of K in maternal plasma was performed from 2003 up to 2010. The test results of each individual assay were collected. Real-time polymerase chain reaction was performed for RHD exon 5 and RHD exon 7, or the specific allele of the RHCE or KEL gene. A stringent diagnostic algorithm was applied. In the case of a negative result, the presence of fetal DNA was ascertained by the analysis of the Y chromosome-specific SRY gene or other paternal genetic markers. Results were compared with available serology after birth or genotyping results of amniotic fluid cells. Percentage of conclusive test results and diagnostic accuracy. A total of 362 tests was performed (D: n = 168; c: n = 49; E: n = 85; K: n = 60). The median gestational age was 17 weeks (range 7-38 weeks). In 351 women (97%), a test result was issued: in seven samples, the presence of fetal DNA could not be confirmed; in two samples, non-specific amplification in the K assay led to an inconclusive result; in two samples, a maternal silent RHD gene prevented fetal RHD genotyping. No false-positive or false-negative results were found among those women for whom cord blood serology or genotyping results of amniotic fluid cells were available (n = 212). Noninvasive fetal blood group genotyping is accurate and applicable in a clinical diagnostic setting.Keywords
This publication has 41 references indexed in Scilit:
- Risk factors for RhD immunisation despite antenatal and postnatal anti‐D prophylaxisBJOG: An International Journal of Obstetrics & Gynaecology, 2009
- Fetal anemia due to non-Rhesus-D red-cell alloimmunizationSeminars in Fetal and Neonatal Medicine, 2008
- Management of Rhesus Alloimmunization in PregnancyObstetrics & Gynecology, 2008
- Effect of screening for red cell antibodies, other than anti‐D, to detect hemolytic disease of the fetus and newborn: a population study in the NetherlandsTransfusion, 2008
- Procedure-Related Complications of Amniocentesis and Chorionic Villous SamplingObstetrics & Gynecology, 2007
- Obstetric History and Antibody Titer in Estimating Severity of Kell Alloimmunization in PregnancyObstetrics & Gynecology, 2007
- Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood—A meta-analysisAmerican Journal of Obstetrics and Gynecology, 2006
- Detection of fetal RHD-specific sequences in maternal plasmaThe Lancet, 1998
- Presence of fetal DNA in maternal plasma and serumThe Lancet, 1997
- Feto‐maternal haemorrhage associated with genetic amniocentesis: results of a randomized trialBJOG: An International Journal of Obstetrics & Gynaecology, 1987